Company Number: 12769523

Analysis Date: 2025-07-19 12:05 UTC

Financial Health Assessment: EMPOWER SUPPLEMENTS LTD (formerly MATT BAKER LTD)

---

1. Financial Health Score: D

Explanation:
The company shows clear symptoms of financial distress, evidenced by persistent negative net current assets (working capital deficit) and net liabilities over multiple years. The absence of significant cash reserves and continuing negative equity position indicate poor financial health and potential solvency concerns.

---

2. Key Vital Signs

Metric	Latest Value (£)	Interpretation
Cash	255	Extremely low cash balance, signaling limited liquidity to cover short-term obligations.
Current Liabilities	1,237	Obligations due within one year exceeding available liquid assets.
Net Current Assets	-982	Negative working capital, indicating the company cannot meet short-term debts with current assets.
Net Assets / Shareholders’ Funds	-982	Negative net worth, showing liabilities exceed assets; a sign of financial distress.
Share Capital	100	Minimal equity capital invested in the company; not enough to buffer losses.
Number of Employees	1	Very small operation, limiting scalability and resource availability.

Interpretation:
The company’s vital signs indicate a "symptom" of financial strain—negative working capital and net assets suggest it is operating "under oxygen deprivation," struggling to sustain its operations without additional funding or restructuring. The very low cash position is a "weak pulse" that could lead to insolvency if not addressed.

---

3. Diagnosis

EMPOWER SUPPLEMENTS LTD’s financial statements reveal persistent negative equity and working capital deficits over at least three years. Despite being active and filing accounts on time, it has not shown improvement in liquidity or solvency. The company is essentially "clinically unwell" financially, with liabilities outstripping its assets and minimal cash reserves to cover short-term debts. The business appears to be in a "critical condition" stage, with significant risk of insolvency if conditions persist.

The small scale of operations (one employee, minimal share capital) and industry involvement in retail, wholesale, and manufacturing of food and pharmaceutical-related products suggest limited operational diversification or asset base to absorb financial shocks.

---

4. Recommendations

a. Immediate Financial Resuscitation:

• Inject fresh capital: The company urgently needs an equity injection or external funding to restore positive net assets and improve liquidity.
• Negotiate creditor terms: Engage creditors to extend payment terms or restructure liabilities to ease short-term cash flow pressures.

b. Operational and Strategic Review:

• Cost control: Audit overheads and operational expenses to identify and reduce unnecessary costs.
• Revenue enhancement: Explore new sales channels or product lines to increase turnover and cash inflows.
• Business model reassessment: Consider pivoting or focusing on more profitable segments given the SIC codes (retail, wholesale, manufacture).

c. Financial Monitoring and Governance:

• Establish robust cash flow management practices to avoid liquidity crunches.
• Maintain transparent communication with stakeholders, including shareholders and creditors.
• Consider appointing a financial advisor or insolvency practitioner for professional restructuring advice if conditions do not improve.

---

Medical Analogy Summary

The company is currently "in a state of financial shock," with "vital signs" indicating poor liquidity and negative equity—a situation akin to a patient with low blood pressure and oxygen deprivation. Without urgent "treatment" in the form of capital infusion and operational restructuring, the prognosis is guarded, with high risk of insolvency.

---